InvestorsHub Logo
Followers 23
Posts 2036
Boards Moderated 0
Alias Born 12/06/2017

Re: None

Monday, 07/26/2021 1:27:50 PM

Monday, July 26, 2021 1:27:50 PM

Post# of 144817
Austrianova Secures $100 Million USD Investment Commitment from GEM Global Yield LLC
This will be a good thing for PMCBD because we own 15% of AN. Eyes will soon turn to PMCB for purchase. Once the IND is opened from the FDA buyers will be jumping on PMCB and there wont be many shares for sale at this low price. There are only approximately 1.6 million shares outstanding common shares now and if a buyer wants to get in they are going to have to pay up. If a big Pharma wants in they will just buy the whole company in one shot. What could the price be once the IND is approved???? $100 a share $200 a share time will tell. Lets see what Dr Hidalgo tells BMY he is on their Board and he is Our PI and designer of our trial and has big beliefs in our treatment.
"Commenting on PharmaCyte’s upcoming clinical trial, renowned oncologist and clinician Dr. Manuel Hidalgo, who will be the Principal Investigator for the trial, said, “The primary goal of the study is to determine the efficacy of this approach, compared to a standard of care treatment, in controlling LAPC. If this endpoint is met, the technology will be validated as a therapeutic option in patients with LAPC.”

Dr. Hidalgo also knows the significance of shrinking tumors in patients with LAPC and stated, “Patients who undergo a successful operation may be indeed cured of the disease. So, if this strategy is able to increase the number of patients that can undergo surgery to remove their previously inoperable tumors, that could be a very important finding.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News